Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1501.00Today’s High
1600.0052W low
1108.6052W High
1600.00Open Price
1504.80Prev. Close
1477.0000Volume
4810254.00Value
7576150050.00Fundamentals
Market Cap
127189.60
Price to Earnings
29.60
Price to Book Value
4.70
Dividend Yield
0.00
PE to Growth
0.80
Op Revenue TTM
26139.14
Net Profit TTM
4303.49
Cash From Operating Activity
4133.91
Return on Equity %
15.43
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
26 Jul, 2024
47.6
Week
59.4
Month
57.6
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1558.67
PIVOT
First Resistance
1616.33
Second Resistance
1657.67
Third Resistance
1715.33
First Support
1517.33
Second Support
1459.67
Third Support
1418.33
Relative Strength Index
68.23
Money Flow Index
57.27
MACD
7.35
MACD Signal
4
Average True Range
31.88
Average Directional Index
14.22
Rate of Change (21)
6.48
Rate of Change (125)
11.78
Commodity Channel Index
320.3
Williams %R
-19.3
BETA
1 Month
1.33
3 Month
0.26
1 Year
0.23
3 Year
0.06
PRICE CHANGE ANALYSIS
↑ 6.02%
1 Week
Low
High
1470.65
1600
↑ 6.48%
1 Month
Low
High
1465.3
1600
↑ 11.77%
3 Months
Low
High
1317.25
1600
↑ 14.99%
6 Months
Low
High
1312
1600
↑ 47.4%
1 Year
Low
High
1108.55
1600
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 4714.57 | 4575.27 | 4550.31 | 4869.81 | 4476.17 | 4013.45 | 4026.57 | 4243.55 | 3274.81 | 3262.92 | 4027.79 | 4132.76 | 4097.07 | |
| Operating Expenses Qtr | 3141.19 | 3208.77 | 3025.47 | 3285.60 | 3113.50 | 3093.96 | 2961.34 | 3090.22 | 2299.75 | 2558.96 | 2914.81 | 2952.21 | 2871.92 | |
| Operating Profit Qtr | 1359.86 | 827.89 | 1355.86 | 1379.12 | 1204.69 | 799.78 | 938.11 | 1061.05 | 857.38 | 387.65 | 1039.98 | 982.82 | 1145.49 | |
| EBIDT Qtr Cr | 1573.38 | 1422.87 | 1621.22 | 1584.21 | 1362.67 | 733.59 | 1065.23 | 1168.44 | 1090.22 | 880.62 | 1112.98 | 1180.55 | 1225.15 | |
| Depreciation Qtr | 137.86 | 136.81 | 135.02 | 179.81 | 135.95 | 161.58 | 129.96 | 176.01 | 107.46 | 116.82 | 133.95 | 138.97 | 136.98 | |
| Net Profit Qtr | 1055.94 | 1038.40 | 1114.14 | 1029.69 | 895.02 | 355.49 | 678.52 | 720.30 | 759.16 | 652.96 | 730.83 | 782.37 | 791.77 | |
| Basic EPS Qtr | 13.08 | 12.86 | 13.80 | 12.76 | 11.09 | 4.40 | 8.41 | 8.74 | 7.98 | 8.09 | 9.06 | 9.70 | 9.82 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 17645.00 | 16247.39 | 13758.49 | 14130.86 | 13552.00 | |
| Operating Expenses Annual Cr | 12090.19 | 11998.02 | 9725.32 | 10179.02 | 9951.86 | |
| Operating Profit Annual | 4484.15 | 3792.58 | 3366.47 | 3721.56 | 2707.29 | |
| Operating Profit Margin Annual % | 25.41 | 23.34 | 24.47 | 26.34 | 19.98 | |
| Total Expenses Annual Cr | 12698.03 | 12620.95 | 10212.26 | 10780.20 | 10587.69 | |
| EBIDT Annual Cr | 5554.81 | 4249.37 | 4033.17 | 3951.84 | 3600.14 | |
| EBIDT Annual margin % | 31.48 | 26.15 | 29.31 | 27.97 | 26.57 | |
| Depreciation | 587.59 | 595.91 | 460.01 | 556.11 | 599.78 | |
| PAT Before ExtraOrdinary Items Annual Cr | 3714.19 | 2469.53 | 2689.39 | 2468.28 | 2318.17 | |
| Net Profit Annual | 4077.25 | 2513.47 | 2957.93 | 2468.28 | 2318.17 | |
| Basic EPS Annual | 50.51 | 31.15 | 36.67 | 30.61 | 28.76 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 27973.92 | 24638.09 | 22513.55 | 19927.56 | 17402.96 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 217.06 | 258.64 | 206.94 | 344.24 | 383.41 | |
| Total Current Liabilities Annual Cr | 2862.25 | 2699.74 | 2728.56 | 2691.94 | 2619.29 | |
| Total Capital Plus Liabilities Annual Cr | 31053.23 | 27596.47 | 25449.05 | 22963.74 | 20405.66 | |
| Fixed Assets Annual | 4388.90 | 4313.25 | 3604.88 | 4421.56 | 4470.71 | |
| Total Non Current Assets Annual | 16146.43 | 14225.34 | 13424.42 | 12771.56 | 11378.60 | |
| Total Current Assets Annual | 14906.80 | 13371.13 | 12024.63 | 10192.18 | 9027.06 | |
| Total Assets Annual | 31053.23 | 27596.47 | 25449.05 | 22963.74 | 20405.66 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 897.09 | 975.31 | 1972.95 | 3121.80 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 3726.77 | 3035.05 | 2773.43 | 3460.31 | 2018.14 | |
| Cash from Investing Activity Annual | -2882.82 | -2757.95 | -2463.73 | -3360.45 | -1126.33 | |
| Cash from Financing Annual Activity | -708.83 | -424.77 | -426.72 | -65.80 | -693.89 | |
| Net Cash Flow Annual | 135.12 | -147.67 | -117.02 | 34.06 | 197.92 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 346.49 | 305.25 | 279.05 | 247.10 | 215.85 | |
| ROE Annual % | 14.57 | 10.20 | 13.13 | 12.38 | 13.32 | |
| ROCE Annual % | 17.61 | 14.67 | 15.72 | 16.75 | 16.86 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 33.51 | 26.91 | 30.80 | 28.42 | 28.43 |
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 6854.13 | 6412.57 | 6788.44 | 6854.47 | 6465.18 | 5873.93 | 5924.53 | 5951.49 | 5478.62 | 5324.35 | 5570.15 | 5580.47 | 5569.28 | |
| Operating Expenses Qtr | 4978.14 | 4847.38 | 4856.28 | 4944.40 | 4834.98 | 4565.56 | 4402.54 | 4526.21 | 4231.84 | 4510.61 | 4247.89 | 4293.60 | 4158.46 | |
| Operating Profit Qtr | 1715.80 | 1315.86 | 1747.53 | 1733.75 | 1493.91 | 1173.74 | 1407.55 | 1302.33 | 1143.35 | 749.72 | 1230.97 | 1226.20 | 1345.89 | |
| EBIDT Qtr Cr | 1875.99 | 1565.19 | 1737.34 | 1910.07 | 1630.20 | 1125.95 | 1521.99 | 1425.28 | 1246.78 | 756.24 | 1322.26 | 1286.87 | 1286.20 | |
| Depreciation Qtr | 246.68 | 288.34 | 233.43 | 290.04 | 239.21 | 346.22 | 272.11 | 299.37 | 254.41 | 290.31 | 247.47 | 253.06 | 261.11 | |
| Net Profit Qtr | 1177.64 | 939.04 | 1055.90 | 1130.91 | 995.70 | 521.51 | 800.96 | 788.90 | 686.40 | 362.07 | 728.60 | 711.36 | 714.72 | |
| Basic EPS Qtr | 14.58 | 11.63 | 13.08 | 14.01 | 12.34 | 6.51 | 9.92 | 9.78 | 8.51 | 4.49 | 9.03 | 8.82 | 8.86 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 26520.66 | 23228.57 | 22044.25 | 19425.58 | 17476.19 | |
| Operating Expenses Annual Cr | 19483.04 | 17726.15 | 17210.56 | 14907.16 | 13926.00 | |
| Operating Profit Annual | 6291.05 | 5026.97 | 4552.78 | 4252.43 | 3205.99 | |
| Operating Profit Margin Annual % | 23.72 | 21.64 | 20.65 | 21.89 | 18.34 | |
| Total Expenses Annual Cr | 20623.94 | 19007.80 | 18368.86 | 16135.52 | 15298.01 | |
| EBIDT Annual Cr | 7037.62 | 5502.42 | 4833.69 | 4518.42 | 3550.19 | |
| EBIDT Annual margin % | 26.54 | 23.69 | 21.93 | 23.26 | 20.31 | |
| Depreciation | 1051.02 | 1172.11 | 1051.95 | 1067.66 | 1174.65 | |
| PAT Before ExtraOrdinary Items Annual Cr | 4155.31 | 2835.49 | 2559.47 | 2401.30 | 1546.98 | |
| Net Profit Annual | 4121.55 | 2801.91 | 2516.75 | 2404.87 | 1546.52 | |
| Basic EPS Annual | 51.01 | 34.69 | 31.17 | 29.79 | 19.16 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 26706.43 | 23407.78 | 20841.69 | 18326.53 | 15763.00 | |
| Minority Interest Liability Annual Cr | 95.90 | 305.76 | 275.69 | 259.06 | 294.28 | |
| Total Non Current Liabilities Annual Cr | 669.72 | 640.07 | 1070.53 | 1974.75 | 3212.14 | |
| Total Current Liabilities Annual Cr | 5245.77 | 5109.67 | 4913.21 | 4591.55 | 4393.14 | |
| Total Capital Plus Liabilities Annual Cr | 32717.82 | 29463.28 | 27101.12 | 25151.89 | 23662.56 | |
| Fixed Assets Annual | 7647.90 | 7269.92 | 7311.58 | 7477.12 | 7573.42 | |
| Total Non Current Assets Annual | 13276.41 | 12188.33 | 12373.58 | 11942.38 | 11956.38 | |
| Total Current Assets Annual | 19441.41 | 17274.95 | 14727.54 | 13209.51 | 11706.18 | |
| Total Assets Annual | 32717.82 | 29463.28 | 27101.12 | 25151.89 | 23662.56 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 1095.87 | 1291.24 | 1178.42 | 1382.19 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 4133.91 | 3237.65 | 3325.90 | 3755.20 | 3068.45 | |
| Cash from Investing Activity Annual | -2988.03 | -2388.51 | -1871.88 | -2387.18 | 104.04 | |
| Cash from Financing Annual Activity | -1200.43 | -958.29 | -1599.79 | -1329.90 | -2948.82 | |
| Net Cash Flow Annual | -54.55 | -109.15 | -145.77 | 38.12 | 223.67 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 331.98 | 293.79 | 261.74 | 230.46 | 199.16 | |
| ROE Annual % | 15.43 | 11.96 | 12.07 | 13.12 | 9.81 | |
| ROCE Annual % | 21.79 | 17.78 | 17.04 | 16.78 | 12.32 | |
| Total Debt to Total Equity Annual | 0.01 | 0.02 | 0.04 | 0.08 | 0.18 | |
| EBDIT Annual Margin % | 27.30 | 24.18 | 22.21 | 23.58 | 20.72 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| HDFC MUTUAL FUND - HDFC FOCUSED 30 FUND | 4.94 | 89037959 | - | - |
| SBI LONG TERM EQUITY FUND | 3.24 | 89037960 | - | - |
| ICICI PRUDENTIAL S&P BSE 500 ETF | 1.12 | 89037961 | - | - |
| GOVERNMENT PENSION FUND GLOBAL | 2.08 | 89037971 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| SOPHIE AHMED | 5.7 | 89037942 | 0 | 0 |
| M K HAMIED | 3.45 | 89037943 | 0 | 0 |
| SAMINA HAMIED | 1.11 | 89037944 | 0 | 0 |
| RUMANA HAMIED | 0.61 | 89037945 | 0 | 0 |
| Yusuf Khwaja Hameid | 18.67 | 89037954 | 0 | 0 |
| Kamil Hamied | 1.36 | 89037955 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| HDFC MUTUAL FUND - HDFC FOCUSED 30 FUND | 4.94 | 89037959 |
| SBI LONG TERM EQUITY FUND | 3.24 | 89037960 |
| ICICI PRUDENTIAL S&P BSE 500 ETF | 1.12 | 89037961 |
| UTI NIFTY INDEX FUND | 1.01 | 89037962 |
| GOVERNMENT PENSION FUND GLOBAL | 2.08 | 89037971 |
| LIC | 3.53 | 89037964 |
| NPS | 1.58 | 89037966 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Aug 02, 2024 | 13 | FINAL | Aug 02, 2024 | Equity Share |
| Jul 21, 2023 | 8.5 | FINAL | Jul 21, 2023 | Equity Share |
| Aug 08, 2022 | 5 | FINAL | Aug 10, 2022 | Equity Share |
| Aug 09, 2021 | 5 | FINAL | - | Equity Share |
| Mar 19, 2020 | 1 | SPECIAL | Mar 20, 2020 | Equity Share |
| Mar 19, 2020 | 3 | INTERIM | Mar 20, 2020 | Equity Share |
| Jul 31, 2019 | 3 | FINAL | - | Equity Share |
| Aug 13, 2018 | 3 | FINAL | - | Equity Share |
| Jul 26, 2017 | 2 | FINAL | - | Equity Share |
| Sep 12, 2016 | 2 | FINAL | - | Equity Share |
| Aug 11, 2015 | 2 | FINAL | - | Equity Share |
| Aug 06, 2014 | 2 | FINAL | - | Equity Share |
| Aug 06, 2013 | 2 | FINAL | - | Equity Share |
| Aug 01, 2012 | 2 | FINAL | - | Equity Share |
| Aug 09, 2011 | 2 | FINAL | - | Equity Share |
| Sep 03, 2010 | 0.8 | INTERIM | Sep 06, 2010 | Equity Share |
| Jul 23, 2010 | 2 | FINAL | - | Equity Share |
| Aug 10, 2009 | 2 | FINAL | - | Equity Share |
| Aug 12, 2008 | 2 | FINAL | - | Equity Share |
| Aug 08, 2007 | 2 | FINAL | - | Equity Share |
| Aug 18, 2006 | 2 | FINAL | - | Equity Share |
| Aug 19, 2005 | 3.5 | FINAL | - | Equity Share |
| Aug 19, 2004 | 3 | FINAL | - | Equity Share |
| Aug 22, 2003 | 10 | FINAL | - | Equity Share |
| Aug 14, 2002 | - | FINAL | - | Equity Share |
| Aug 06, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|---|---|
| May 11, 2004 | 10:2 | 2004-05-19 |
| Ex-Date | Purpose | Notes |
|---|---|---|
| Jul 26, 2024 | Quarterly Results | - |
| May 10, 2024 | Audited Results & Final Dividend | - |
| Jan 22, 2024 | Quarterly Results | (Revised) |
| Oct 27, 2023 | Quarterly Results | - |
| Jul 26, 2023 | Quarterly Results | - |
| May 12, 2023 | Audited Results & Final Dividend | - |
| Jan 25, 2023 | Quarterly Results | - |
| Nov 04, 2022 | Quarterly Results | - |
| Jul 29, 2022 | Quarterly Results | - |
| May 10, 2022 | Audited Results & Dividend | - |
| Jan 25, 2022 | Quarterly Results | - |
| Oct 26, 2021 | Quarterly Results | - |
| Aug 05, 2021 | Quarterly Results | - |
| May 14, 2021 | Audited Results & Dividend | - |
| Jan 29, 2021 | Quarterly Results | - |
| Nov 06, 2020 | Quarterly Results | - |
| Aug 07, 2020 | Quarterly Results | - |
| May 15, 2020 | Audited Results & Others | Inter-alia to Obtain an enabling approval from the shareholders at the forthcoming AGM of the Company regarding the proposal of raising of funds through issue of securities. |
| Mar 12, 2020 | Interim Dividend | - |
| Feb 05, 2020 | Quarterly Results | - |
| Nov 06, 2019 | Quarterly Results | - |
| Aug 07, 2019 | Quarterly Results | - |
| May 22, 2019 | Others | inter-alia also consider obtaining an enabling approval from the shareholders at the forthcoming AGM of the Company regarding the proposal of raising of funds through issue of securities. |
| Feb 06, 2019 | Quarterly Results | - |
| Nov 05, 2018 | Quarterly Results | - |
| Aug 08, 2018 | Quarterly Results | - |
| May 22, 2018 | Audited Results, Dividend & Others | Inter-alia also consider obtaining an enabling approval from the shareholders at the forthcoming AGM of the Company regarding the proposal of raising of funds through issue of securities. |
| Feb 07, 2018 | Quarterly Results | - |
| Nov 07, 2017 | Quarterly Results | - |
| Aug 11, 2017 | Quarterly Results | - |
| May 25, 2017 | Audited Results & Dividend | - |
| Feb 08, 2017 | Quarterly Results | - |
| Dec 19, 2016 | Issue of Equity Shares | - |
| Nov 09, 2016 | Quarterly Results | - |
| Aug 12, 2016 | Quarterly Results | - |
| Jun 08, 2016 | Appointment of CFO | - |
| May 24, 2016 | Audited Results & Dividend | Recommended the appointment of Walker Chandiok & Co LLP, Chartered Accountants, as statutory auditors of the Company. |
| Feb 10, 2016 | Quarterly Results | - |
| Nov 05, 2015 | Quarterly Results | Re-appointed Mr. S. Radhakrishnan as a Whole-time Director for a term of two years with effect from November 12, 2015. |
| Aug 14, 2015 | Quarterly Results | - |
| Jul 09, 2015 | Appointment of Directors | - |
| May 29, 2015 | Audited Results & Dividend | - |
| Feb 12, 2015 | Quarterly Results | - |
| Nov 13, 2014 | Quarterly Results | - |
| Aug 14, 2014 | Quarterly Results | - |
| May 29, 2014 | Audited Results & Dividend | - |
| Feb 12, 2014 | Quarterly Results | - |
| Nov 13, 2013 | Quarterly Results | - |
| Aug 09, 2013 | Quarterly Results | - |
| May 29, 2013 | Audited Results & Dividend | - |
| Feb 06, 2013 | Quarterly Results | - |
| Nov 05, 2012 | Quarterly Results | - |
| Jul 31, 2012 | Quarterly Results | - |
| Jun 07, 2012 | Audited Results & Dividend | - |
| May 10, 2012 | Quarterly Results | - |
| Feb 13, 2012 | Quarterly Results | - |
| Nov 14, 2011 | Quarterly Results | - |
| Aug 05, 2011 | Quarterly Results | - |
| Jun 29, 2011 | Audited Results & Dividend | - |
| May 05, 2011 | Quarterly Results | - |
| Feb 04, 2011 | Quarterly Results | - |
| Nov 11, 2010 | Quarterly Results | - |
| Aug 25, 2010 | Special Interim Dividend & Others | To consider special interim dividend for the FY 2010-2011 & to approve the acquisition of Meditab Specialities Pvt. Ltd. for an aggregate consideration of Rs. 133.35 Crs. |
| Aug 13, 2010 | Quarterly Results | - |
| Jun 15, 2010 | Audited Results, Dividend & Others | For acquisition of 40% stake in a biotech Co. based in India through subscription of fresh Shares & 25% stake in a biotech Co. in Hong Kong through subscription of fresh Shares of the Company. |
| May 07, 2010 | Quarterly Results & Others | For acquisition of two manufacturing facilities which hitherto were manufacturing formulations and bulk drugs / intermediates exclusively for Cipla Ltd. for an aggregate consideration of Rs. 82.02 Cr. |
| Jan 28, 2010 | Quarterly Results | - |
| Oct 28, 2009 | Quarterly Results | - |
| Jul 29, 2009 | Quarterly Results & Others | To raise funds upto Rs 1500 Crs by further issue of securities in domestic / international markets through various instruments including equity shares / warrants with NCD's under QIPs / FCCBs & etc. |
| Jul 15, 2009 | Audited Results & Dividend | - |
| Apr 24, 2009 | Quarterly Results | - |
| Jan 22, 2009 | Quarterly Results | - |
| Oct 22, 2008 | Quarterly Results | - |
| Jul 18, 2008 | Audited, Quarterly Results & Dividend | - |
| Apr 25, 2008 | Quarterly Results | - |
| Jan 24, 2008 | Quarterly Results | - |
| Oct 24, 2007 | Quarterly Results | - |
| Jul 20, 2007 | Audited Results, Dividend & Qtr Results | - |
| Apr 26, 2007 | Quarterly Results | - |
| Jan 23, 2007 | Quarterly Results | - |
| Oct 20, 2006 | Quarterly Results | - |
| Jul 21, 2006 | Accounts, Dividend & Qtr Results | - |
| Apr 25, 2006 | Quarterly Results | - |
| Feb 11, 2006 | Bonus Issue & Issue of securities | Increase in the limit of investment by Foreign Institutional Investors into the paid-up capital / securities of the Company. |
| Jan 24, 2006 | Quarterly Results | - |
| Oct 27, 2005 | Quarterly Results | - |
| Jul 25, 2005 | Accounts, Dividend & Quarterly Results | - |
| Apr 26, 2005 | Quarterly Results | - |
| Jan 18, 2005 | Quarterly Results | - |
| Oct 26, 2004 | Quarterly Results | - |
| Jul 23, 2004 | Quarterly Results & Dividend | - |
| Apr 21, 2004 | Quarterly Results | - |
| Mar 23, 2004 | Stock Split | - |
| Jan 30, 2004 | Quarterly Results | - |
| Oct 31, 2003 | Quarterly Results | - |
| Jul 28, 2003 | Dividend & Quarterly Results | - |
| Apr 25, 2003 | Quarterly Results | - |
| Jan 18, 2003 | Quarterly Results | - |
| Oct 22, 2002 | Quarterly Results | - |
| Jul 24, 2002 | Accounts & Dividend | - |
| Apr 29, 2002 | Quarterly Results | - |
| Mar 04, 2002 | Interim Dividend | - |
| Jan 19, 2002 | Quarterly Results | - |
| Oct 20, 2001 | Quarterly Results | - |
| Jul 26, 2001 | Accounts, Dividend & Quarterly Results | - |
| Apr 26, 2001 | Quarterly Results | - |
| Jan 30, 2001 | Quarterly Results | - |
| Oct 24, 2000 | Quarterly Results | - |
| Jul 26, 2000 | Quarterly Results | - |
| Apr 27, 2000 | Quarterly Results | - |
| Mar 22, 2000 | Interim Dividend | - |
| Aug 06, 1999 | Bonus Issue | - |
| Jul 22, 1999 | Accounts, Dividend & Quarterly Results | - |
| Jan 28, 1999 | Quarterly Results | - |
| Oct 29, 1998 | Quarterly Results | - |
| Nov 14, 1997 | Half Yearly Results | - |
| Jul 24, 1997 | Accounts & Dividend | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
| Apr 24, 2006 | 3:2 | 2006-04-25 |
26 Jul 2024
CIPLA LTD. - 500087 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for FY 2023-24
26 Jul 2024
CIPLA LTD. - 500087 - Notice Of The 88Th Annual General Meeting Along With A Copy Of The Integrated Annual Report For FY 2023-24
Notice of the 88th Annual General Meeting along with a copy of the Integrated Annual Report for FY 2023-24
26 Jul 2024
CIPLA LTD. - 500087 - Reg. 34 (1) Annual Report.
Notice of the 88th Annual General Meeting along with a copy of the Integrated Annual Report for FY 2023-24
26 Jul 2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, the audio recording of the earnings conference call for Q1 FY25 held today is available on the Company's website at https://www.cipla.com/audio/12007
26 Jul 2024
Cipla looks at newer areas of growth, including neurology, mental health
Promoter family's Samina Hamied resigns from board as Non-Executive Director
26 Jul 2024
Q1FY25 Quarterly Result Announced for Cipla Ltd.
Pharmaceuticals company Cipla announced Q1FY25 results: Financial Highlights: Income from Operations: Rs 6,694 crore, up by 7% YoY EBITDA: Rs 1,716 crore, up by 14% YoY PAT: Rs 1,178 crore, up by 17% YoY Business Highlights: One-India: India Branded Prescription Business grew at a healthy rate of 10% YoY. Overall One India growth was offset by softness in Trade Generics Business owing to distribution model change. North America: All-time high revenue at USD 250 million up by 13% YoY supported by traction in differentiated portfolio. South Africa: Momentum continues with revenue growth at 19% in local currency terms. Prescription business ranked #1 in the market R&D; investments: stand at Rs 353 crore or 5.3 % of sales, higher by 1% YoY driven by product filings and developmental efforts. Strong net cash: Net cash position of Rs 8,449 crore; Debt primarily includes lease liabilities and working capital requirements. Compliance update: Patalganga and Kurkumbh facilities were classified as ‘VAI’ by USFDA. Umang Vohra MD and Global CEO, Cipla said: I am pleased to share that we continue to make considerable progress across our focused markets. In Q1FY25, we recorded revenue growth of 7% over last year with EBITDA margin of 25.6% driven by mix and other operational efficiencies. Our One-India business continued on its growth trajectory during the quarter, led by Branded Prescription which grew at 10%. Our concentrated focus and execution in differentiated portfolio have further strengthened the US business which yet again posted all-time high quarterly revenue at USD 250 million. In South Africa, we recorded a solid growth of 19% YoY in local currency terms, led by Private Market. Going ahead, focus will be on growing our key markets, further building our flagship brands, investing in future pipeline as well as focusing on resolutions on the regulatory front”. Result PDF
26 Jul 2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Change in Management
Appointment of SMP
26 Jul 2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Change in Directorate
Change in directors of the Company.
26 Jul 2024
CIPLA LTD. - 500087 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th July 2024
Outcome of the Board Meeting held on 26th July 2024
26 Jul 2024
CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication of consolidated unaudited financial results for the quarter ended 30th June 2024
